Guardant Nabs Key ACS Nod and Liquid Biopsy Approval
ACS now lists Shield as a choice for CRC screening of adults age 45 and older who are at average risk of the disease, who have not completed, or have declined v...
ACS now lists Shield as a choice for CRC screening of adults age 45 and older who are at average risk of the disease, who have not completed, or have declined visual exams and stool tests. The post Guardant Nabs Key ACS Nod and Liquid Biopsy Approval appeared first on Inside Precision Medicine .